Ironwood Pharmaceuticals Cash Flow Statement (2009-2026) | IRWD

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	391.30M	55.87M	41.38M	38.77M	37.08M	50.32M	48.87M	45.71M	-1089.52M	13.93M	-228.28M	-4.16M	-0.82M	3.67M	-96.76M	-37.37M	23.62M	40.08M	-122.63M	40.77M
Depreciation and Depletion (Quarter)	0.40M	0.36M	0.36M	0.35M	0.36M	0.36M	0.34M	0.29M	0.27M	0.51M	0.51M	0.51M	0.51M	0.51M	0.48M	0.48M	0.47M	0.47M	0.46M	0.44M
Share-based Compensation (Quarter)	4.59M	6.21M	6.09M	6.09M	6.60M	7.07M	7.29M	7.13M	8.26M	7.91M	8.70M	8.38M	8.57M	8.33M	4.57M	5.29M	4.52M	3.61M	3.82M	3.65M
Deferred Taxes (Quarter)		2.57M	1.93M	14.71M	14.89M	16.02M	20.13M	17.05M	10.01M	14.26M	31.32M	6.05M	13.26M	7.68M	41.10M	0.67M	14.11M	27.77M	-1.75M	19.20M
Cash from Discontinued Operations (Quarter)
Gains from Sales and Divestitures (Quarter)			1.70M				1.33M				0.07M				0.80M				0.19M
Gains from Investment Securities (Quarter)	3.08M	-5.57M	9.30M	-0.42M	-0.75M	-0.15M	5.93M	-0.02M				0.62M	0.12M		-0.81M			-0.01M	0.00M
Asset Writedowns and Impairment (Quarter)
Non-cash Items (Quarter)			4.53M				5.79M				2.92M				4.54M				3.40M
Cash from Operations (Quarter)	48.57M	75.06M	64.57M	64.12M	61.37M	69.09M	79.18M	80.17M	34.96M	32.46M	35.83M	44.98M	33.47M	9.88M	15.21M	19.95M	-15.07M	47.58M	74.58M	5.12M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)												0.38M	0.39M	0.39M	0.40M	0.41M	0.42M	0.43M	0.43M	0.44M
Amortization of Deferred Charges (Quarter)	5.93M	6.04M	6.15M	0.54M	0.52M	0.40M	0.40M	0.40M	0.48M	0.59M	0.59M	0.59M	0.55M	0.35M	0.41M	0.42M	0.42M	0.42M	0.42M	0.42M
Depreciation & Amortization (CF) (Quarter)	0.40M	0.36M	0.36M	0.35M	0.36M	0.36M	0.34M	0.29M	0.27M	0.51M	0.51M	0.51M	0.51M	0.51M	0.48M	0.48M	0.47M	0.47M	0.46M	0.44M
Change in Working Capital
Change in Receivables (Quarter)	15.24M	-0.33M	12.41M	-18.38M	-3.01M	14.34M	-0.94M	-14.30M	3.24M	5.56M	4.58M	-57.11M	-13.91M	18.09M	5.68M	-42.12M	46.40M	34.19M	-73.62M	59.10M
Change in Inventory (Quarter)
Change in Accured Expenses (Quarter)	7.66M	-6.43M	5.44M	3.62M	-14.38M	4.66M	-2.01M	0.70M	3.36M	20.86M	-12.55M	-12.53M	19.47M	4.47M	-31.63M	9.66M	-5.81M	2.66M	-0.32M	-0.22M
Other Working Capital Changes (Quarter)	0.38M	-1.29M	0.76M	-0.04M	-0.93M	-0.60M	1.43M	-0.03M	-0.94M	-0.51M	1.80M	-0.52M	3.06M	-1.56M	-3.15M	-0.57M	0.29M	-1.48M	1.39M	-0.62M
Investing Activities
Capital Expenditures (Quarter)			0.13M	0.01M	0.09M	0.07M	-0.03M	0.01M		0.05M	0.21M	0.07M	0.06M	0.02M		0.03M	0.00M	0.00M	-0.00M
Sales of Property, Plant and Equipment (Quarter)
Divestments (Quarter)
Change in Acquisitions & Divestments (Quarter)
Cash from Investing Activities (Quarter)			-0.13M	-0.01M	-0.09M	-0.07M	0.03M	-0.01M	-999.49M	-22.62M	-4.19M	-0.07M	-0.06M	-0.02M		-0.03M	-0.00M	-0.00M	0.00M
Financing Activities
Other financing activities (Quarter)	5.67M	6.13M	17.45M	1.52M	4.32M	0.80M	5.16M	1.63M	1.37M	0.01M	1.71M	10.06M	0.75M	-8.65M	0.09M	0.01M	0.09M	0.00M	-0.09M	-0.00M
Cash from Financing Activities (Quarter)	5.66M	6.16M	-18.59M	-90.87M	-150.28M	0.80M	2.81M	3.98M	399.07M	-74.99M	-50.90M	-15.55M	-49.37M	-27.16M	-14.89M	0.01M	0.09M		0.12M
Additional items
Exchange Rate Effect (Quarter)											-0.05M	0.02M	-0.05M	-0.03M	0.02M	-0.01M	-0.65M	-0.03M	0.35M	-0.11M
Change in Cash (Quarter)	54.23M	81.09M	45.85M	-26.76M	-89.01M	69.82M	82.02M	84.14M	-565.46M	-65.16M	-19.31M	29.39M	-16.02M	-17.31M	0.35M	19.92M	-15.63M	47.55M	75.05M	5.01M
Free Cash Flow (Quarter)	48.57M	75.06M	64.44M	64.11M	61.28M	69.03M	79.21M	80.16M	34.96M	32.41M	35.62M	44.92M	33.41M	9.87M	15.21M	19.92M	-15.07M	47.58M	74.58M	5.12M
Net Cash Flow (Quarter)	54.23M	81.23M	45.85M	-26.76M	-89.01M	69.82M	82.02M	84.14M	-565.46M	-65.15M	-19.26M	29.36M	-15.96M	-17.29M	0.33M	19.93M	-14.98M	47.58M	74.70M	5.12M

Research Tools

Ironwood Pharmaceuticals Cash Flow Statement (2009-2026) | IRWD

Create an account

Sign In

Reset Password